<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
54348-625-10
</NDCCode>
<PackageDescription>
1 BOTTLE in 1 BOX (54348-625-10) > 10 TABLET in 1 BOTTLE
</PackageDescription>
<NDC11Code>
54348-0625-10
</NDC11Code>
<ProductNDC>
54348-625
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Sulfamethox-tmp Ds
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sulfamethoxazole, Trimethoprim
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20190711
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA076899
</ApplicationNumber>
<LabelerName>
PharmPak, Inc.
</LabelerName>
<SubstanceName>
SULFAMETHOXAZOLE; TRIMETHOPRIM
</SubstanceName>
<StrengthNumber>
800; 160
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1
</StrengthUnit>
<Pharm_Classes>
Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Sulfonamides [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2022-10-12
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20190711
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>